COPD Flashcards

1
Q

Definition?

A

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease state characterised by airflow limitation that is not fully reversible. It encompasses both emphysema and chronic bronchitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors strong?

A
  • Smoking
  • Advanced age
  • Genetics
  • Occupational problems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk factors weak?

A
  • White
  • Air pollution
  • Developmental problems
  • Male
  • Low SE status
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Differentials?

A
  • Asthma
  • Congestive heart failure
  • Bronchiectasis
  • Tuberculosis
  • Bronchiolitis
  • Upper airway dysfunction
  • Chronic sinusitis/post-nasal drip
  • GORD
  • ACE inhibitor induced chronic cough
  • Lung cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Epidemiology?

A

Age: over 65’s
Sex: Male-recently equal
Ethnicity: White
Prevalence: Fourth leading cause of death in the world, 3 million in UK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Aetiology?

A

Smoking induces an inflammatory response, cilia dysfunction and oxidative stress by increasing proteinases that break down the cell lining in bronchioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clinical Presentation-common?

A
  • Risk factors
  • Cough
  • SOB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical Presentation-uncommon?

A
  • Barrel chest
  • Hyper-resonance on percussion
  • Distant breath sounds and poor air movement
  • Wheezing
  • Coarse crackles
  • Tachypnoea
  • Asterixis
  • Distended neck veins
  • Swelling
  • Fatigue
  • Headache
  • Cyanosis
  • Hepatojugular reflux
  • Loud P2
  • Hepatosplenomegaly
  • clubbing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pathophysiology of Chronic Bronchitis?

A

• Inflammation causes mucociliary dysfunction and increased goblet cell secretions and numbers so more mucus is made
• Bronchoconstriction and mucus hypersecretion causes airway obstruction and chronic cough and wheezing in expiration
• Airway obs-alveolar hypoxia-V/Q mismatch and pulmonary VC-leads to pulmonary hypertension and backflow to RV and so cor pulmonale and increased JVP
• Also less circulatory volume causes RAAS activation and so extra fluid retention
Obstruction-leads to hypoxaemia and hypercapnia and resp acidosis and polycythaemia and lead to cyanosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pathophysiology of Emphysema?

A
  • Inflammatory response due to irritants stimulating macrophages attracting neutrophils and that secrete elastase leading to elastin breakdown in alveoli walls and so recoil is lost so less ventilation
  • Or a1 antitrypsin deficiency-more proteases and less anti-proteases-breakdown of elastin/alveoli walls
  • Also destruction of capillary beds and alveoli wall leading to decreased perfusion
  • Leads to air trapping in alveolus in exhalation-higher end expiratory vol-cant empty lungs and accessory muscle used-barrel chest
  • Mismatched V/Q -hypoxaemia and hypercapnia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

First line investigations and findings?

A
  • spirometry (FEV1/FVC ratio <0.70),
  • pulse oximetry (88-90% or pulse wave),
  • ABG (PaCO₂ >50 mmHg and/or PaO₂ of <60 mmHg suggests respiratory insufficiency)
  • CXR-increased anteroposterior ratio, flattened diaphragm, increased intercostal spaces, and hyperlucent lungs may be seen.
  • FBC-raised haematocrit, possible increased WBC count
  • BMI
  • ECG-signs of right ventricular hypertrophy, arrhythmia, ischaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

2nd line investigations and findings?

A
2nd line:
• Pulmonary function tests
• Chest CT
• Sputum culture
• Alpha-1 antitrypsin level
• Exercise testing
• Sleep study
• Resp muscle function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Management group A?

A

Info, smoking cessation, vaccines, anxiety and depression, management, inhaled therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management group B?

A

Info, smoking cessation, vaccines, anxiety and depression, management, inhaled therapy, oral therapy and oxygen therapy-LABA and LAMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management group C?

A

Info, smoking cessation, vaccines, anxiety and depression, management, inhaled therapy, oral therapy and oxygen therapy-LABA and LAMA and ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management group D?

A

Info, smoking cessation, vaccines, anxiety and depression, management, inhaled therapy, oral therapy and oxygen therapy-LABA and LAMA and ICS, roflumilast and lung vol reduction/palliative care

17
Q

Complications?

A
Cor pulmonale
• Recurrent pneumonia
• Depression and anxiety
• Pneumothorax
• Resp failure
• Anaemia
• Polycythaemia
• Reduced quality of life
• Lung cancer
18
Q

Prognosis?

A
  • 50% 5 yr mortality following hospitalisation for COPD exacerbation
  • Outcomes vary per pt
  • May need pulmonary rehab
19
Q

Definition of exacerbation?

A

Acute worsening of respiratory COPD symptoms that requires further intervention

20
Q

Risk factors of E-strong?

A
  • Bacterial infection
  • GORD
  • Viral infection
  • Pollutants
21
Q

Risk factors of E-weak?

A
  • Change in weather

* Atypical bacterial infection

22
Q

Differentials of E?

A
  • Acute exacerbation of asthma
  • Congestive heart failure
  • Pneumonia
  • Pleural effusion
  • Pneumothorax
  • PE
  • Cardiac ischaemia
  • Cardiac arrhythmia
  • Upper airway obstruction
  • Inappropriate oxygen therapy
23
Q

Aetiology of E?

A
  • Exacerbations due to infections and pollutants causing airway inflammation and associated symptoms
  • Bacterial-Haemophilus influenzae, Moraxella catarrhalis, strep. Pneumoniae and pseudomonas aeruginosa
24
Q

Clinical Presentation of E?

A
  • Dyspnoea
  • Cough
  • Increased sputum
  • Wheeze
  • Chest tightness
  • Tachypnoea
  • Tachycardia
  • Risk factors
  • Cor pulmonale
  • Resp failure signs
  • Fever
  • GORD
25
Q

Pathophysiology of E?

A

Sudden onset of inflammatory responses lead to airway obstruction

26
Q

1st line investigations and findings of E?

A

• ABG-(PaO2<8.0 kPa (approximately 60 mmHg) indicatesrespiratory failure, pH <7.35 and PaCO2>6.5 kPa define acute respiratory acidosis)
• Pulse oximetry-low oxygen saturation, depressed below the patient’s baseline level
• ECG-may be right heart enlargement, arrhythmia, ischaemia
• FBC with platelets-may show elevated haematocrit, elevated WBC count, or anaemia
• Urea, electrolytes and creatinine-normal
• CRP-elevated CRP suggests presence of infection
• CXR-hyperinflation, flattened diaphragm, increased retrosternal air space (seen on lateral x-ray, if performed), bullae, and a small vertical heart suggesive
• Sputum microscopy, culture and gram stain-bacterial infection
Vit D-<10 ng/mL or <25 nM indicates severe deficiency

27
Q

2nd line investigations and findings of E?

A
  • Blood cultures-sepsis
  • Resp virus diagnostics-viral
  • Cardiac troponin-MI
  • Serum theophylline-therapeutic range: 10-20 mg/L (55–110 micromols/litre)
  • Pro=BNP-normal BNP <100 picograms/mL but some variability according to gender and age
  • CT chest-may still show presence of emphysema, even if no pneumonia, pleural effusion, malignancy, or pulmonary embolus present
  • Spirometry-only if previous results are unavailable
28
Q

Acute management?

A
  • SABA
  • ICS
  • Oxygen -Start on 24-28% and titrate up/down depending on ABG or sats
  • Ventilation
  • Antibiotic therapy-amino penicillin, clavulanic acid, macrolides and tetracycline or ceftazidime for PA
  • Supplemental-co-morbidities, fluid , nutritional, DVT prophylaxis
29
Q

Monitoring?

A
  • ABG, pulse oximetry
  • Review meds and smoking cessation services
  • Assisted discharge scheme
  • Pulmonary rehab
  • Education
  • Supervision and correction of inhaler technique
  • Assessment and management of comorbidities
  • Telemonitoring
  • Continuing patient contact.
30
Q

Complications of E?

A
  • Mechanical ventilation and ventilator-associated pneumonia
  • Antibiotic-related diarrhoea
  • Mechanical ventilation and ventilator-associated barotrauma
  • Hypotension due to mechanical ventilation